Clin2
NCT07701928Possibly a fitNot yet recruiting

Sleep medication for insomnia and alcohol use disorder

Alcohol Use DisorderInsomnia

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study tests a sleep medication called daridorexant to see if it helps people with both insomnia and alcohol use disorder sleep better and reduce drinking. It may offer a new way to address both problems together.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
205 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have trouble sleeping at least 3 nights a week for at least 3 months
  • You drink 4 or more standard drinks on at least 4 occasions in the past month
  • You have been diagnosed with alcohol use disorder
  • You are willing to seek treatment for both sleep and alcohol problems
  • You can read and speak English

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07532252Not yet recruiting· Phase 2
Medication for alcohol problems and sleep

This study tests whether a medication called daridorexant helps people with alcohol use disorder by improving their sleep and possibly helping them reduce or stop drinking. If you have trouble sleeping and want to cut back on alcohol, this trial might be a fit.

NCT07847021Not yet recruiting
Daridorexant for adults with insomnia

This study follows adults with insomnia who are prescribed a new sleep medication called daridorexant. It aims to see how well the medication works in a real-world setting, and to monitor its safety and effects on sleep.

Chaohu, Anhui
NCT07555743Not yet recruiting· Phase 4
Sleep drug test for people with depression and insomnia

This study tests an experimental sleep aid called daridorexant for people who have both depression and insomnia. It aims to see if the drug can improve sleep without worsening depression symptoms.

Barcelona, Catalonia
NCT07328594Not yet recruiting· Phase 4
Sleep medication study for smokers wanting to cut back

This study tests a sleep medication called daridorexant to see if it helps smokers sleep better and feel more alert during the day, which might make it easier to cut back on smoking. You'll take the medication for 3 weeks and track your sleep and smoking at home.

Portland, Oregon
NCT06326684Recruiting· Early Phase 1
Testing suvorexant for alcohol use disorder

This study tests whether the sleep medication suvorexant can help people with alcohol use disorder drink less. It involves a short stay where you'll receive either suvorexant or a placebo and then have alcohol.

Lexington, Kentucky
NCT07214207Recruiting· Phase 2
Testing a sleep medicine for alcohol use disorder and stress-related drinking

This trial tests whether a medicine called suvorexant, which is used for sleep, can help people with alcohol use disorder drink less, especially when stressed. You would receive the medicine or a placebo, and researchers will track your drinking and stress levels over several weeks.

Columbus, Ohio

Hear when a new Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.